Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: 2 Arm Study of Clofarabine IV in MDS Patients [Phase 2]
Phase 2 trial evaluating intravenous Clofarabine in patients with myelodysplastic syndrome and leukemia has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia [Phase 1]
Phase 1 trial of dasatinib in children and adolescents with relapsed or refractory leukemia has completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-19Clinical Trial Update: A Phase I Trial of ZIO-101 in Hematologic Cancers [Phase 1]
This document reports the completion status of a Phase I trial evaluating ZIO-101 in hematologic cancers sponsored by Alaunos Therapeutics.
-
CLINICAL_TRIALS trial_result · 2012-07-17Clinical Trial Update: Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial evaluating donor stem cell transplantation after conditioning with busulfan, fludarabine, and antithymocyte globuli…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML [Phase 2]
Phase 2 trial investigating chemotherapy, total-body irradiation, donor NK cell infusion, Aldesleukin, and umbilical cord blood transplant f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-06-27Clinical Trial Update: Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions [Phase 1]
Phase 1 clinical trial update on HLA Class I haplotype-mismatched natural killer cell infusions for hematologic cancers, including lymphoma,…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 trial investigating donor stem cell or donor white blood cell infusions in hematologic cancers; the study is terminated with results…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Radiation Therapy and Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With High-Grade Lymphoma or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
This clinical trial update reports Phase 1/2 results for a treatment regimen of radiation therapy and chemotherapy followed by peripheral st…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation [Phase 2]
Phase 2 trial of peripheral blood lymphocyte therapy using EBV-specific cytotoxic T cells to prevent EBV-related lymphoproliferative disorde…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a phase 1/2 study evaluating peripheral stem cell transplantation in patients with brea…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial update evaluating stem cell transplantation as treatment for hematologic cancers. The study includes patients with various hem…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 clinical trial update on bone marrow and peripheral stem cell transplantation for patients with hematologic cancers; the study statu…
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders [NA]
Clinical trial update for a study evaluating G-CSF–treated donor bone marrow transplant in hematologic disorders; the trial (NCT00253552) is…
-
CLINICAL_TRIALS trial_result · 2012-05-22Clinical Trial Update: Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial evaluating natural killer (NK) cell adback after allogeneic stem cell transplant with Campath-IH plus chemoradiation …
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the combination of liposomal doxorubicin (Doxil) and bortezomib in patients with refractory hematol…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Cellular Therapy With Cord Blood Cells [Phase 2]
Phase 2 trial evaluating cord blood cell–based cellular therapy in patients with multiple myeloma, leukemia, or lymphoma. Results were poste…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas [Phase 1]
A Phase 1 safety study of SNX-5422 for solid tumor malignancies and lymphoid cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Chemotherapy in Treating Patients Who Have Hematologic Cancer [Phase 1]
A Phase 1 chemotherapy trial sponsored by Daiichi Sankyo for leukemia and myelodysplastic syndromes has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating paclitaxel in patients with refractory or recurrent acute leukemia or chronic myelogenous leukemia has…
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial evaluating umbilical cord blood-derived mesenchymal stem cells to promote engraftment in unrelated hemato…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Azacitidine, Darbepoetin Alfa, and Erythropoietin and Filgastrim (G-CSF) in Treating Patients With Myelodysplastic Syndromes [Phase 2]
Phase 2 trial of azacitidine, darbepoetin alfa, erythropoietin, and G-CSF in myelodysplastic syndromes; study terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2012-03-19Clinical Trial Update: Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study [EARLY_Phase 1]
Completed EARLY Phase 1 pilot trial evaluating the effects of health counseling and exercise in patients with acute leukemia.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J
Clinical trial update on the use of arsenic trioxide in young patients with leukemia or lymphoma treated on NCI-00-C-0070J.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating umbilical cord blood transplantation for high-risk hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2012-03-15Clinical Trial Update: Tipifarnib in Treating Young Patients With Refractory Leukemia [Phase 1]
A Phase 1 trial assessing Tipifarnib in young patients with refractory leukemia has completed.